Table 2.
Neuropsychological sequelae and management
| All patients* | HVI | LVI | P value | |
| Acute cohort | ||||
| No of patients | 59 | 26 | 31 | |
| Neuropsychological sequelae, no (%) | 14 (24) | 6 (23) | 7 (23) | >0.99 |
| Long-term cohort | ||||
| No of patients | 122 | 51 | 69 | |
| Days to first follow-up, median (IQR)† | 201 (68–766) | 504 (179–1236) | 124 (41–233) | <0.001 |
| Days to last follow-up, median (IQR)† | 980 (391–1409) | 1099 (511–1651) | 773 (315–1218) | 0.02 |
| Neuropsychological sequelae, no (%) | ||||
| <5 years postinjury | 99 (81) | 42 (82) | 56 (81) | >0.99 |
| >5 years postinjury‡ | 20 (27) | 13 (35) | 7 (20) | 0.19 |
| Psychological/ psychiatric treatment, no (%) |
78 (64) | 31 (61) | 47 (68) | 0.44 |
| Medication, no (%) | 78 (64) | 30 (59) | 47 (68) | 0.34 |
Analysis excludes patients with documented pre-existing psychiatric conditions.
*Includes patients whose voltage was not otherwise specified (acute cohort, n=2; long-term cohort, n=2).
†Calculated from the date of injury.
‡Percentages are calculated based on the total number of patients that were available for follow-up at >5 years postinjury (all patients, n=74; HVI, n=37; LVI, n=35).
HVI, high-voltage injury; LVI, low-voltage injury.